Your shopping cart is empty




You are about to log out of VaccineShoppe.com.

Would you like to place your order before you log out?

Log Out Continue Shopping

Prescribing Information

Before administering Imogam Rabies-HT immune globulin, please see full Prescribing Information.

Reimbursement Information

Imogam® Rabies-HT

Rabies Immune Globulin (Human) USP, Heat Treated

Log in to order

About Imogam Rabies-HT Immune Globulin

IMPORTANT SAFETY INFORMATION FOR IMOGAM RABIES-HT IMMUNE GLOBULIN

Imogam Rabies-HT immune globulin should not be given in repeated doses once vaccine treatment has begun.

Imogam Rabies-HT immune globulin is made from components of human blood. Therefore, it may carry a risk of transmitting infectious agents.

Persons who have been previously immunized with a rabies vaccine prepared from human diploid cells (HDCV), purified chick embryo cell vaccine (PCEC), or Rabies Vaccine Adsorbed (RVA) in a preexposure or postexposure treatment series should receive only vaccine.

Local adverse reactions to the Imogam Rabies-HT immune globulin include tenderness, pain, and soreness or stiffness of the muscles at the injection site. Although mild systemic adverse reactions to the globulin after intramuscular injection are uncommon, Imogam Rabies-HT immune globulin should be given with caution to patients with a history of prior systemic allergic reactions following the administration of human immune globulin. Other adverse reactions may occur. Treatment with a rabies immune globulin may not protect all individuals. 

INDICATION FOR IMOGAM RABIES-HT IMMUNE GLOBULIN

Imogam Rabies-HT immune globulin is indicated for passive immunization of individuals suspected of exposure to rabies.

Guides, Materials, & Brochures

 

Safety Data Sheet (SDS)

This website requires the use of cookies, but your web browser is not accepting them. Please enable cookies in order to use this site.
OK